Operating Lease, Right-of-Use Asset of ABEONA THERAPEUTICS INC. from 01 Jan 2019 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
ABEONA THERAPEUTICS INC. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 30 Sep 2025.
  • ABEONA THERAPEUTICS INC. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $4,086,000, a 7.8% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

ABEONA THERAPEUTICS INC. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $4,086,000 +$297,000 +7.8% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 $4,144,000 +$120,000 +3% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 $4,239,000 +$17,000 +0.4% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 $3,552,000 -$903,000 -20% 31 Dec 2024 10-Q 12 Nov 2025 2025 Q3
Q3 2024 $3,789,000 -$896,000 -19% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $4,024,000 -$891,000 -18% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $4,222,000 -$882,000 -17% 31 Mar 2024 10-Q 15 May 2024 2024 Q1
Q4 2023 $4,455,000 -$876,000 -16% 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $4,685,000 -$1,953,000 -29% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $4,915,000 -$2,028,000 -29% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $5,104,000 -$2,436,000 -32% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $5,331,000 -$4,072,000 -43% 31 Dec 2022 10-K 18 Mar 2024 2023 FY
Q3 2022 $6,638,000 +$431,000 +6.9% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 $6,943,000 +$454,000 +7% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $7,540,000 +$776,000 +11% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 $9,403,000 +$2,371,000 +34% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $6,207,000 -$1,088,000 -15% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 $6,489,000 -$1,062,000 -14% 30 Jun 2021 10-Q 28 Jul 2021 2021 Q2
Q1 2021 $6,764,000 -$1,038,000 -13% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 $7,032,000 -$1,015,000 -13% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 $7,295,000 -$991,000 -12% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $7,551,000 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $7,802,000 -$1,098,000 -12% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $8,047,000 -$853,000 -9.6% 31 Dec 2019 10-K 24 Mar 2021 2020 FY
Q3 2019 $8,286,000 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q1 2019 $8,900,000 31 Mar 2019 10-Q 10 May 2019 2019 Q1
Q4 2018 $8,900,000 01 Jan 2019 10-Q 09 Aug 2019 2019 Q2
* An asterisk sign (*) next to the value indicates that the value is likely invalid.